FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124125658> ?p ?o ?g. }

• W2124125658 endingPage "1166" @default.
• W2124125658 startingPage "1166" @default.
• W2124125658 abstract "To determine the comparative efficacy of topical gatifloxacin with ciprofloxacin, fortified amikacin, and clarithromycin against Mycobacterium chelonae keratitis in an animal model.Experimental M chelonae keratitis was induced via intrastromal inoculation in a rabbit model. Thirty-five rabbits were randomly divided into 5 groups and each group was treated hourly for 12 hours with topical 0.9% balanced salt solution, 0.3% gatifloxacin, 0.3% ciprofloxacin hydrochloride, a combination of topical fortified amikacin sulfate (50 mg/mL) and clarithromycin (10 mg/mL), or a triple combination of topical 0.3% gatifloxacin, fortified amikacin sulfate (50 mg/mL), and clarithromycin (10 mg/mL). Antibacterial efficacy of each regimen was determined by quantitative bacteriologic analysis.Treatment with 0.3% gatifloxacin or the triple combination of 0.3% gatifloxacin, topical fortified amikacin sulfate (50 mg/mL), and clarithromycin (10 mg/mL) reduced the number of mycobacterial organisms more significantly than the controls that were treated with a topical balanced salt solution (both P<.001). Therapy with 0.3% gatifloxacin was more effective than 0.3% ciprofloxacin alone (P<.001) and demonstrated synergy by enhancing the efficacy of the combination of fortified amikacin (50 mg/mL) and clarithromycin (10 mg/mL) (P<.001). Neither 0.3% ciprofloxacin nor the combination of fortified amikacin (50 mg/mL) and clarithromycin (10 mg/mL) demonstrated a significant difference in activity against mycobacteria compared with the topical balanced salt solution.These results suggest that topical 0.3% gatifloxacin ophthalmic solution can be a new initial treatment agent against M chelonae keratitis.Clinical Relevance Topical gatifloxacin 0.3% may provide an initial alternative in therapy of M chelonae keratitis." @default.
• W2124125658 created "2016-06-24" @default.
• W2124125658 creator A5017031167 @default.
• W2124125658 creator A5036696955 @default.
• W2124125658 creator A5065087774 @default.
• W2124125658 creator A5065106184 @default.
• W2124125658 creator A5065318636 @default.
• W2124125658 creator A5088805911 @default.
• W2124125658 date "2004-08-01" @default.
• W2124125658 modified "2023-10-18" @default.
• W2124125658 title "Comparative Efficacy of Topical Gatifloxacin With Ciprofloxacin, Amikacin,and Clarithromycin in the Treatment of Experimental Mycobacteriumchelonae Keratitis" @default.
• W2124125658 cites W112538211 @default.
• W2124125658 cites W1502853560 @default.
• W2124125658 cites W1510934485 @default.
• W2124125658 cites W1974629289 @default.
• W2124125658 cites W1976009048 @default.
• W2124125658 cites W1978545518 @default.
• W2124125658 cites W1984260425 @default.
• W2124125658 cites W1985235810 @default.
• W2124125658 cites W1985859896 @default.
• W2124125658 cites W2014892643 @default.
• W2124125658 cites W2022976293 @default.
• W2124125658 cites W2023511616 @default.
• W2124125658 cites W2050580456 @default.
• W2124125658 cites W2058948251 @default.
• W2124125658 cites W2073369215 @default.
• W2124125658 cites W2077729895 @default.
• W2124125658 cites W2087472966 @default.
• W2124125658 cites W2104185725 @default.
• W2124125658 cites W2119787658 @default.
• W2124125658 cites W2143374200 @default.
• W2124125658 cites W2313446360 @default.
• W2124125658 cites W2345227154 @default.
• W2124125658 cites W2414511661 @default.
• W2124125658 cites W2419302751 @default.
• W2124125658 doi "https://doi.org/10.1001/archopht.122.8.1166" @default.
• W2124125658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15302657" @default.
• W2124125658 hasPublicationYear "2004" @default.
• W2124125658 type Work @default.
• W2124125658 sameAs 2124125658 @default.
• W2124125658 citedByCount "36" @default.
• W2124125658 countsByYear W21241256582012 @default.
• W2124125658 countsByYear W21241256582013 @default.
• W2124125658 countsByYear W21241256582014 @default.
• W2124125658 countsByYear W21241256582015 @default.
• W2124125658 countsByYear W21241256582017 @default.
• W2124125658 countsByYear W21241256582020 @default.
• W2124125658 countsByYear W21241256582021 @default.
• W2124125658 countsByYear W21241256582022 @default.
• W2124125658 countsByYear W21241256582023 @default.
• W2124125658 crossrefType "journal-article" @default.
• W2124125658 hasAuthorship W2124125658A5017031167 @default.
• W2124125658 hasAuthorship W2124125658A5036696955 @default.
• W2124125658 hasAuthorship W2124125658A5065087774 @default.
• W2124125658 hasAuthorship W2124125658A5065106184 @default.
• W2124125658 hasAuthorship W2124125658A5065318636 @default.
• W2124125658 hasAuthorship W2124125658A5088805911 @default.
• W2124125658 hasBestOaLocation W21241256581 @default.
• W2124125658 hasConcept C118487528 @default.
• W2124125658 hasConcept C126322002 @default.
• W2124125658 hasConcept C142724271 @default.
• W2124125658 hasConcept C2776100946 @default.
• W2124125658 hasConcept C2776409635 @default.
• W2124125658 hasConcept C2776962512 @default.
• W2124125658 hasConcept C2777427914 @default.
• W2124125658 hasConcept C2777653605 @default.
• W2124125658 hasConcept C2778512257 @default.
• W2124125658 hasConcept C2778560704 @default.
• W2124125658 hasConcept C2780374374 @default.
• W2124125658 hasConcept C2781069245 @default.
• W2124125658 hasConcept C501593827 @default.
• W2124125658 hasConcept C71924100 @default.
• W2124125658 hasConcept C86803240 @default.
• W2124125658 hasConcept C89423630 @default.
• W2124125658 hasConcept C98274493 @default.
• W2124125658 hasConceptScore W2124125658C118487528 @default.
• W2124125658 hasConceptScore W2124125658C126322002 @default.
• W2124125658 hasConceptScore W2124125658C142724271 @default.
• W2124125658 hasConceptScore W2124125658C2776100946 @default.
• W2124125658 hasConceptScore W2124125658C2776409635 @default.
• W2124125658 hasConceptScore W2124125658C2776962512 @default.
• W2124125658 hasConceptScore W2124125658C2777427914 @default.
• W2124125658 hasConceptScore W2124125658C2777653605 @default.
• W2124125658 hasConceptScore W2124125658C2778512257 @default.
• W2124125658 hasConceptScore W2124125658C2778560704 @default.
• W2124125658 hasConceptScore W2124125658C2780374374 @default.
• W2124125658 hasConceptScore W2124125658C2781069245 @default.
• W2124125658 hasConceptScore W2124125658C501593827 @default.
• W2124125658 hasConceptScore W2124125658C71924100 @default.
• W2124125658 hasConceptScore W2124125658C86803240 @default.
• W2124125658 hasConceptScore W2124125658C89423630 @default.
• W2124125658 hasConceptScore W2124125658C98274493 @default.
• W2124125658 hasIssue "8" @default.
• W2124125658 hasLocation W21241256581 @default.
• W2124125658 hasLocation W21241256582 @default.
• W2124125658 hasOpenAccess W2124125658 @default.
• W2124125658 hasPrimaryLocation W21241256581 @default.
• W2124125658 hasRelatedWork W1976009048 @default.

• next